UPDATE: Goldman Sachs Downgrades 10X Genomics (TXG) to Sell
Tweet Send to a Friend
(Updated - August 18, 2022 5:08 AM EDT)
Goldman Sachs analyst Matthew Sykes downgraded 10X Genomics (NASDAQ: TXG) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Matthew Sykes downgraded 10X Genomics (NASDAQ: TXG) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
